Strides Arcolab trades higher on the bourses

26 Jun 2014 Evaluate

Strides Arcolab is currently trading at Rs. 625.75, up by 4.00 points or 0.64% from its previous closing of Rs. 621.75 on the BSE.

The scrip opened at Rs. 624.95 and has touched a high and low of Rs. 630.30 and Rs. 617.95 respectively. So far 36253 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1050.00 on 05-Dec-2013 and a 52 week low of Rs. 343.80 on 26-Feb-2014.

Last one week high and low of the scrip stood at Rs. 638.80 and Rs. 591.00 respectively. The current market cap of the company is Rs. 3716.89 crore.

The promoters holding in the company stood at 27.67% while Institutions and Non-Institutions held 51.95% and 20.38% respectively.

Strides Arcolab has received ANDA approval for its skin drug Imiquimod Creme by United States Food & Drug Administration (USFDA). This is first product approval from Beltapharm, the company’s UFDA approved semi solids facility in Milan, Italy. The product will be marketed directly by Strides in the US market.

Imiquimod Creme is a topical skin creme indicated for the treatment of certain types of actinic keratoses on the face or scalp, and the external genital and perianal warts in patients, aged 12 years or older. According to IMS data, the US market for generic Imiquimod Creme is approximately $140 million.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

896.45 20.40 (2.33%)
30-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1502.30
Dr. Reddys Lab 6198.90
Cipla 1402.20
Zydus Lifesciences 957.00
Lupin 1645.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.